Leucine metabolism in patients with Cushing's syndrome before and after successful treatment

作者: S. B. Bowes , J. J. Benn , I. N. Scobie , A. M. Umpleby , C. Lowy

DOI: 10.1111/J.1365-2265.1993.TB02414.X

关键词: Internal medicineMetabolismCushing syndromeEndocrinologyLean body massProtein turnoverPathophysiologyWeight lossMoleLeucineBiology

摘要: Summary OBJECTIVE Results from studies on the effect of glucocor-ticosteroids protein turnover in both rat and man have been conflicting. The aim this study was to investigate primary cause muscle wasting patients with Cushing's syndrome. DESIGN Studies whole body 1-14C-leucine syndrome before after successful treatment, control subjects. PATIENTS Eleven (n= 5) treatment 11 subjects. MEASUREMENTS Whole determine leucine metabolic clearance rate, production oxidation rate incorporation into protein. RESULTS Plasma concentration (mean ± SEM 100 6 μ mol/l), (9.97 0.11 mol/min/kg), (0.98 mol/min/kg) (0.71 0.09 were all significantly reduced compared subjects (122 mol/l, P < 0.05; 13.61 1.27 mol/min/kg, 1.65 0.12 1.46 0.10 0.001, respectively). Leucine similar subjects. When metabolism expressed terms lean mass (LBM) five subjects, MCR, not different two groups. However, (P< 0.001) (1.07 0.20 mol/min kg LBM) (1.95 mol/min/kg LBM). CONCLUSION We conclude these that associated is primarily due a reduction synthesis.

参考文章(30)
B R Odedra, P C Bates, D J Millward, Time course of the effect of catabolic doses of corticosterone on protein turnover in rat skeletal muscle and liver Biochemical Journal. ,vol. 214, pp. 617- 627 ,(1983) , 10.1042/BJ2140617
R M Fulks, J B Li, A L Goldberg, Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. Journal of Biological Chemistry. ,vol. 250, pp. 290- 298 ,(1975) , 10.1016/S0021-9258(19)42013-9
PAOLO TESSARI, SANDRO INCHIOSTRO, GIANNI BIOLO, MARIA CRISTINA MARESCOTTI, GIUSEPPE FANTIN, MARIA TERESA BOSCARATO, GENNARO MEROLA, FRANCO MANTERO, ANTONIO TIENGO, Leucine kinetics and the effects of hyperinsulinemia in patients with Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. ,vol. 68, pp. 256- 262 ,(1989) , 10.1210/JCEM-68-2-256
S. W. J. LAMBERTS, J. C. BIRKENHAGER, Body composition in Cushing's disease. The Journal of Clinical Endocrinology and Metabolism. ,vol. 42, pp. 864- 868 ,(1976) , 10.1210/JCEM-42-5-864
R. NOSADINI, S. DEL PRATO, A. TIENGO, A. VALERIO, M. MUGGEO, G. OPOCHER, F. MANTERO, E. DUNER, C. MARESCOTTI, F. MOLLO, F. BELLONI, Insulin resistance in Cushing's syndrome. The Journal of Clinical Endocrinology and Metabolism. ,vol. 57, pp. 529- 536 ,(1983) , 10.1210/JCEM-57-3-529
F F Horber, M W Haymond, Human growth hormone prevents the protein catabolic side effects of prednisone in humans. Journal of Clinical Investigation. ,vol. 86, pp. 265- 272 ,(1990) , 10.1172/JCI114694
Shin'ichi Shoji, Ronald J.T. Pennington, The effect of cortisone on protein breakdown and synthesis in rat skeletal muscle Molecular and Cellular Endocrinology. ,vol. 6, pp. 159- 169 ,(1977) , 10.1016/0303-7207(77)90082-X
A. A. KHALEELI, R. H. T. EDWARDS, K. GOHIL, G. McPHAIL, M. J. RENNIE, J. ROUND, E. J. ROSS, Corticosteroid myopathy: a clinical and pathological study Clinical Endocrinology. ,vol. 18, pp. 155- 166 ,(1983) , 10.1111/J.1365-2265.1983.TB03198.X
S. B. Bowes, J. J. Benn, I. N. Scobie, A. M. Umpleby, C. Lowy, P. H. Sonksen, Glucose metabolism in patients with Cushing's syndrome. Clinical Endocrinology. ,vol. 34, pp. 311- 316 ,(1991) , 10.1111/J.1365-2265.1991.TB03772.X